Vaginoscopy approach with Mechanical Tissue Removal System for AUB inPediatric Aplastic Anemia: a case report Authors: Dong Ding, Shengpeng Zhang, Xiaoyu Shi, Xiaohui Hou, Xinxin Zou, Limin Feng Published: 2025 ABSTRACT BackgroundAplastic anemia (AA) is a rare childhood blood disease characterized by anemia, infection, and a tendency for hemorrhage. AA may present as abnormal uterine bleeding (AUB) and intrauterine infection in female patients with menstrual cycles. The management of AA-associated AUB in pediatric patients remains a significant challenge due to the absence of established, comprehensive guidelines. We report a rare case of a patient who successfully underwent bone marrow transplantation (BMT) after treatment with vaginoscopy combined with a mechanical hysteroscopic tissue removal system (mHTRs).Case presentationA 10-year-old female patient, diagnosed with AA for four years, presented with heavy menstrual bleeding (HMB) and lower abdominal pain accompanied by fever for ten days. To ensure she could proceed with her scheduled BMT, she required management for AUB and suspected intrauterine infection. We removed the lesion via innovative vaginoscopy combined with mHTRs. Through multidisciplinary cooperation and a precise blood transfusion strategy, the procedure achieved the objects of endometrium protection, hymen preservation, and hematological safety.ConclusionFor pediatric patients with AA-associated AUB, the combination of vaginoscopy and mHTRs represents a promising surgical alternative. Compared to traditional approaches, this technique allows minimally invasive lesion resection while preserving endometrium and hymen integrity, addressing the main concern for pediatric patients. Furthermore, integrating multidisciplinary expertise and precise transfusion management ensures the safety of surgery and hemodynamics. This approach provides a clinically feasible, patient-tailored solution for a complex population with limited treatment options.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12893-025-03393-8. Background Aplastic anemia (AA) is a rare childhood blood disease characterized by persistent hypocellular bone marrow and pancytopenia without dysplasia or marrow fibrosis [1]. The typical clinical symptoms include anemia, infection, and a tendency towards hemorrhage. Female pediatric patients with AA may present with gynecological emergencies, such as intrauterine infection and abnormal uterine bleeding (AUB) clinically manifested as heavy menstrual bleeding (HMB) [2, 3]. For those scheduled for bone marrow transplantation (BMT), it is crucial to address any active infections before the procedure [4]. The protection of hymen integrity, preservation of endometrium and hematologic safety were the unique challenges during the management of gynecologic emergencies in non-sexually active pediatric AA patients. This report describes the first documented case of a pediatric AA patient presenting with AUB and suspected intrauterine infection, who was successfully managed via hysteroscopic vaginoscopy combined with a mechanical hysteroscopic tissue removal system (mHTRs). Multidisciplinary collaboration and a precise transfusion strategy were implemented throughout the procedure, ensuring the patient’s safety. Case presentation A 10-year-old female patient (37 kg) with no history of sexual activity, was admitted to the gynecology ward due to HMB and lower abdominal pain accompanied by fever over the past 10 days. This patient, originally diagnosed with AA in December 2020, had precious received chemotherapy and later switched to Mongolian medicine (a form of traditional Chinese medicine) 2 years prior due to persistently elevated uric acid levels. She experienced menarche on August 9th, 2023. Within two months, she began suffering from intermittent HMB, characterized by prolonged duration of 20 days and a three-fold increase in volume. Hemostatic Mongolian medicine and monthly platelet (PLT) infusions were administered to control the bleeding. However, her situation deteriorated in November 2024, with uncontrollable bleeding and fever. Discontinuation of Mongolian medicine and initiation of combined oral contraceptives (COCs) and progestogen failed to alleviate symptoms. Although antibiotic treatment at the previous hospital temporarily reduced her fever, it did not resolve completely. Ten days before admission, she developed lower abdominal pain. Transrectal ultrasound revealed a heterogeneous, slightly hyperechoic area measuring 5.9×3.0 cm from the uterus to cervical canal and the upper vagina (Fig. 1). The previous hospital recommended BMT and scheduled the procedure for January 2025. Consequently, she was admitted for definitive management of the intrauterine lesion and optimization of her clinical status prior to BMT. Fig. 1Transrectal ultrasound revealing the location and size of the abnormal intrauterine tissue. A B-mode ultrasonography revealing a heterogeneous, slightly hyperechoic area measuring 5.9×3.0 cm in the uterine to cervical canal and the upper vagina. B Color Doppler flow imaging (CDFI) revealing a few flow signals in bundle around the tissue, and no obvious flow signals in most of the slightly hyperechoic areas Transrectal ultrasound revealing the location and size of the abnormal intrauterine tissue. A B-mode ultrasonography revealing a heterogeneous, slightly hyperechoic area measuring 5.9×3.0 cm in the uterine to cervical canal and the upper vagina. B Color Doppler flow imaging (CDFI) revealing a few flow signals in bundle around the tissue, and no obvious flow signals in most of the slightly hyperechoic areas During the examination, the patient appeared pale but was hemodynamically stable, with a pulse of 98 beats per minute and blood pressure of 111/80 mmHg. Her chest X-ray was normal and her temperature fluctuated between 37.5–37.8℃. Her blood routine results upon admission were as follows: White blood cell (WBC) count of 0.75×10^9/L, Red blood cell (RBC) count of 1.54×10^12/L, PLT count of 46×10^9/L, hemoglobin level of 46 g/L and C-reactive protein (CRP) level of 108.87 mg/L (Table 1). Based on the imaging studies including ultrasound and chest X-ray, choriocarcinoma, pediatric tumors, arterio-venous fistula and leiomyosarcoma were excluded. Table 1Blood routine results and blood transfusionTimeWhite blood cell (*109/L)Red blood cell (*1012/L)Platelet (*109/L)Hemoglobin (g/L)CRP (mg/L)One day before surgery0.751.544646108.87400ml of RBC were transfused 1 day before surgeryThe morning of surgery0.432.453275/250ml of single-donor apheresis PLT was transfused and the surgery was performed after 1 hour200ml of RBC and 200ml of fresh frozen plasma were infused during the surgeryOne day after surgery0.592.49987536.54 Table 1Blood routine results and blood transfusionTimeWhite blood cell (*109/L)Red blood cell (*1012/L)Platelet (*109/L)Hemoglobin (g/L)CRP (mg/L)One day before surgery0.751.544646108.87400ml of RBC were transfused 1 day before surgeryThe morning of surgery0.432.453275/250ml of single-donor apheresis PLT was transfused and the surgery was performed after 1 hour200ml of RBC and 200ml of fresh frozen plasma were infused during the surgeryOne day after surgery0.592.49987536.54 Blood routine results and blood transfusion A multidisciplinary team, including hematology and infectious disease specialists, evaluated the patient. With informed consent from the patient and her guardian, antibiotic therapy with meropenem was initiated within the first 3 days of admission. Additionally, 400 mL of red blood cells (RBC) and 250 mL of platelets (PLT) were transfused 24h and 1h prior to the gynecological procedure respectively. The surgical procedure used the SWD-MPS-I-C manufactured by Hangzhou Sode Medical Equipment Co. Ltd, which is a type of tissue removal instrument similar to Integrated Bigatti Shaver (IBS®). Preoperative examination confirmed the hymen was intact without iatrogenic tears or damage. Without employing a vaginal speculum, an 8-mm-diameter hysteroscopic vaginoscope was inserted into the uterine cavity, revealing a dark red, decidual-like endometrium prolapsed from the internal ostium of the uterus. After approximately 40 min of exploration, a 6×5×5 cm mass was identified occupying the entire uterine cavity. Under continuous ultrasound guidance, a 4-mm-diameter blade mHTRs was utilized to resect the intrauterine tissue in a layered fashion at a speed of 5000 rpm (Fig. 2). Active bleeding occurred during the resection. To promote uterine contraction and reduce bleeding, a methyl carboprost suppository was administered rectally, and targeted electrocoagulation was applied for precise hemostasis. After completely removing the mass, the normal uterine cavity architecture was restored, including bilateral oviduct ostia and pale pink endometrium. A total of 8000 ml of normal saline was used as the uterine distension fluid during the 2-hour 10-minute procedure. To prevent water intoxication due to distension medium, 10 ml of furosemide was administered intravenously, and continuous ultrasound monitoring was maintained during the surgery. Two intraoperative arterial blood gas analyses showed no evidence of dilutional hyponatremia or fluid overload. Blood loss was strictly monitored, with 200 ml of RBC and 200 ml of fresh frozen plasma transfused when the loss reached 500 ml. Total amount of blood loss was estimated at 1200 ml. Blood pressure and heart rate were continuously monitored. Postoperative examination confirmed preserved hymenal integrity. Fig. 2Vaginoscopy images. The mHTRs removing the intrauterine lesions Vaginoscopy images. The mHTRs removing the intrauterine lesions On the night after the operation, the abdominal pain had subsided and the temperature had not risen again. The blood routine results one day after the procedure were as follows: WBC count 0.59×10^9/l, RBC count 2.49×10^12/l, PLT count 98 × 10^9/l, hemoglobin 75 g/l and CRP 36.54 mg/L (Table 1). After clinical stabilization and discharged, the patient promptly returned for BMT. During the follow-up, she was instructed to continue taking COCs and progestogen, with gradually tapering planned until discontinuation. After six months of follow-up, the patient and her guardian were rejoiced in the successful BMT and the non-recurrence of HMB. An ultrasound performed one month later revealed a normal uterine cavity with an endometrial thickness of 0.6 cm. Histopathological evaluation demonstrated marked decidual transformation of the endometrial stroma with glandular reduction. Most glandular epithelia showed post-secretory atrophy, while a minority exhibited secretory-phase features, consistent with norethindrone-related changes. Associated findings included hemorrhagic necrosis and scattered lymphocytic infiltration. Owing to the patient’s critical condition, bacteriological culture was not performed. However, the clinical improvement and histopathological findings are compatible with an ascending vaginal bacterial infection and subsequent intrauterine tissue necrosis as the probable etiology. Discussion Clinical challenges of gynecological emergencies associated with AA AA in childhood is a rare blood disorder, characterized by persistent hypocellular bone marrow and pancytopenia without dysplasia or marrow fibrosis [1]. BMT has been an established treatment for AA, and the survival rate of pediatric patients has reached 90% [5–7]. The typical AA triad, including anemia, infection, and hemorrhage, occurred in this case. Given that there was a plan for BMT, the risks of pre-BMT management for her were mainly manifested in the following two aspects. Firstly, the conditioning regimens for BMT would lead to profound immunosuppression, and any uncontrolled infection could potentially cause fatal sepsis [4]. Secondly, the patient’s severe anemia and thrombocytopenia posed an extreme bleeding risk during any surgical procedure. Thus, clinical management faced a critical dilemma. Neglecting the intrauterine infection would preclude BMT, while operating under such hematologic conditions entailed a high mortality risk from hemorrhage. This highlights the essential role of the multidisciplinary collaboration among hematology, gynecology, and anesthesiology in the management of gynecological emergencies in AA patients [3]. During the procedure, the anesthesiologist selected general anesthesia by evaluating the PLT level and continuously monitored the changes in blood pressure and heart rate, while the hematologist guided the transfusion timing and components selection. Supported by this coordinated effort, the gynecologic team was able to safely perform the surgery with careful attention to hemostasis. Selection of operation plans and technical innovations for adolescent patients with gynecological diseases For AUB patients with AA, initial management prioritizes non-surgical interventions, such as hormonal therapy (e.g. COCs) and gonadotropin-releasing hormone agonist (GnRH-a) [8–11]. However, this conservative therapy could not solve the intrauterine pathological focus that our patient had in addition to AUB. Consequently, surgical intervention was indicated. Surgical intervention for pediatric with AUB associated with AA and no sexual history should focus on three key objectives: preserving endometrium, minimizing damage to the hymen, and ensuring effective hemostasis. Conventional methods such as endometrial ablation, hysterectomy, and uterine artery embolization are not recommended for pediatric patients due to long-term complications including infertility [11]. Ultrasound-guided traditional uterine curettage and hysteroscopy are alternative for patients who request fertility preservation, but the use of vaginal speculums renders these approaches unsuitable for patients without sexual experience. The intrauterine Foley balloon catheter tamponade has successfully treated AUB in some cases, but is not suitable for this patient due to its requirement of normal uterine cavity [12, 13]. Additionally, the levonorgestrel-releasing intrauterine system (LNG-IUS) can suppress endometrial growth and reduce menstrual volume [14]. It has also been proven to be effective in managing AUB in adult patients with AA [15]. However, this intervention was not adopted in our case due to the patient’s pediatric status and the unavailability of appropriately sized devices for her immature uterus. In contrast, the no-touch hysteroscopic (vaginoscopy) is more suitable for gynecological procedure in pediatric patients without sexual activity, as it minimized hymenal damage and significantly reduces procedural pain [16–18]. The combined use of mHTRs allows precise excision of infected necrotic tissue. The mHTRs utilizes mechanical energy to simultaneously resect and aspirate pathological tissue. Compared to resectoscope, mHTRs offers improved visual clarity, reduced risk of thermal injury, and greater control over resection depth [19–21]. Additionally, studies have shown that mHTRs can shorten operative time and decrease the volume of distension fluid required [20, 22]. According to the study by G. Bigatti et al. [22], the operation time for adult polypectomy and myomectomy with Integrated Bigatti Shaver (IBS®) ranges from 3 to 66 min. Our operation lasted 2h 10 min, which was longer than the duration reported. The lesions reported in the study ranged from 0.8 cm to 4 cm, while in our pediatric patient with AA, the lesion measured 6×5×5 cm. More careful intraoperative manipulation and hemostasis were necessary to protect the endometrial basal layer and reduce blood loss. We introduce a novel strategy integrating vaginoscopy and mHTRs to manage AA-related AUB and infection in pediatric patients. This integrated technique allows complete removal of infected tissue and precise point-to-point hemostasis under direct visualization, while enabling selective resection of the endometrial functional layer without compromising the basal layer, thereby maximizing fertility preservation. Regarding postoperative management, oral COCs were used instead of injecting GnRH-a. This option facilitated easier administration and improved compliance in the pediatric patient. Perioperative blood transfusion management in patients with AA Patient blood management (PBM) is advocated for perioperative pediatric patients, which focus on the patient rather than transfusion. PBM aims to achieve the safe management of blood loss and anemia, and minimize unnecessary blood transfusion [23]. Guidelines recommend that correcting anemia preoperatively and maintaining platelet (PLT) counts above 50×10⁹/L, with transfusion considered only when indicated [24, 25]. The restrictive blood transfusion strategy is advised when hemoglobin levels remain ≥70 g/L [24, 26]. In collaboration with hematology, we implemented an individualized, time-stratified transfusion plan. RBC were transfused 24h before surgery to raise hemoglobin, and PLT were administered 1h preoperatively to optimize hemostasis [27]. Based on the patient’s weight (37 kg), her estimated blood volume ranged between 2590 and 2960 mL, and an intraoperative transfusion threshold was set at 20% of this volume. And timely transfusion was performed. Given her postoperative hemoglobin of 75 g/L and hemodynamic stability, a restrictive transfusion approach was maintained. No additional blood products were utilized to minimize the risk of alloimmunization or transfusion-related blood-borne diseases. Through careful timing and selection of blood components, hemodynamic stability was maintained and ineffective PLT transfusion was avoided. Conclusion In this study, we implemented an innovative approach used hysteroscopic vaginoscopy combined with mHTRs to manage intrauterine infection and control AUB in pediatric patients with AA. This technique successfully preserved hymenal integrity and minimized endometrial damage, thereby protecting future fertility. Hematological safety was maintained through a multidisciplinary strategy including tailored transfusion support. The combination of minimally invasive mHTRs technology and a precise transfusion strategy can achieve the objects of endometrium protection, hymen preservation, and hematological safety in pediatric blood-disease-related gynecological emergencies. Our approach provides a viable treatment option for such high-risk patients. The surgical outcome can be evaluated through postoperative ultrasound, blood routine test, CRP and menstruation. Additionally, considering the unique characteristics of pediatric gynecologic surgery compared to adults, as well as the current lack of standardized protocols and clinical guidelines for pediatric gynecologic interventions, our surgical approach, multidisciplinary collaboration and transfusion strategy can serve as a reference for clinical practice. Supplementary Information Supplementary Material 1. Supplementary Material 1. Supplementary Material 2. Supplementary Material 2.